Unfortunately, your browser is too old to work on this website. Please upgrade your browser
Skip to main content
Analysis

How efficiency varies across NHS acute trusts

Published 3 July 2026
Last updated 3 July 2026
Time to read clock icon About 11 mins
Authors

Key points

  • The COVID-19 pandemic triggered a decline in NHS efficiency, which has yet to fully recover. Less care is now being delivered than would be expected given the resources available. In response, the government has set a target to achieve 2% annual efficiency growth, partly by narrowing variation in performance.
  • This analysis examines the extent of variation across trusts and whether reducing it could improve efficiency nationally. We found that the most efficient trusts are around 1.6 times as efficient as the least – a gap that has remained stable since before the pandemic.
  • The overall decline in efficiency mainly reflects inputs (such as staff, equipment and operating costs) increasing at a faster rate than outputs (admissions, appointments, procedures). Between 2018/19 and 2024/25, our measured inputs increased by 30%, with outputs increasing by only 12%, equivalent to an efficiency shortfall of 14%.
  • This decline in efficiency is reflected across most trusts, including the highest performers, suggesting that sluggish pandemic recovery reflects system-wide constraints rather than poor performance among a small group of trusts.
  • Trusts with lower efficiency levels are disproportionately teaching and research intensive, and current output measures may only partially capture these activities. This highlights the need for more refined efficiency measures to better target areas for improvement.
  • While there is some potential to improve system-wide efficiency by reducing variation between trusts, this on its own will not be enough to improve national efficiency over the long term. A more effective approach would combine efforts to reduce variation with broader strategies aimed at improving efficiency across all trusts.
 

Introduction

Over the past few years, the NHS has expanded its workforce and received substantial funding increases. Yet activity (for example, the number of appointments or procedures) has not risen proportionately, reflecting a sustained decline in efficiency – that is, how effectively ‘inputs’ such as staff, beds and equipment are being turned into ‘outputs’ (admissions, appointments, procedures). 

This means less care is being delivered than would be expected given the resources available, contributing to longer waits for treatment. Recent work has documented this ‘productivity puzzle’ and explored the reasons behind it. NHS England has also developed more granular productivity measures that track activity and input levels over time to better understand performance across the system.

The decline in NHS efficiency is a relatively recent phenomenon. Between 1995/96 and 2018/19, the Office for National Statistics (ONS) estimated that NHS efficiency had grown by an average of 0.6% per year, rising to 1% when adjusted for the quality of care. The pandemic triggered a sharp reversal, with efficiency falling by around a quarter. While measures from the ONS and NHS England saw some recovery by 2022/23, efficiency still remained below levels seen a decade earlier. 

Restoring efficiency growth has become a central policy objective. The government has set a target to achieve 2% annual efficiency growth, partly by narrowing variation in performance between trusts. Understanding the extent to which the national efficiency level could be increased by reducing such variation is critical for policymakers.

This analysis examines how NHS efficiency has changed since the pandemic, the extent of variation across trusts and whether reducing that variation could provide a feasible route to improving efficiency nationally. Specifically, we ask whether the national decline in efficiency is being driven by a downward shift in efficiency levels across all trusts or a widening of variation between them. 

 

What we mean by ‘productivity’ and ‘efficiency’

Health care productivity describes the relationship between the resources used and the care delivered. When productivity rises, the NHS can provide more or better care without additional investment in staff, technology or capital. When it falls, even large funding increases may not translate into higher levels of care.

Productivity is hard to measure and can be defined in different ways. The most commonly used measure is technical efficiency: how effectively inputs such as staff time and equipment are being converted into outputs such as consultations, procedures and admissions. However, there are legitimate concerns about an overly narrow focus on technical efficiency. Many argue that productivity should be defined more broadly to reflect how care translates into health outcomes (effectiveness) and whether the right care is being delivered in the first place (allocative efficiency). These concepts are being explored by our NHS Productivity Commission.

Nevertheless, improving technical efficiency is important. When resources remain unchanged, higher efficiency indicates more care is being provided with the same inputs. Improving technical efficiency and reducing variation across the NHS are central policy objectives reflected in the NHS Productivity Plan and reiterated in the 10 Year Health Plan. This includes aims to ‘close the productivity gap back to 2019/20 and level up worst performers with operational and clinical productivity improvements’, and the publication of a new trust-level efficiency dataset.

Our analysis therefore focuses on technical efficiency, using an approach close to the ONS non-quality-adjusted measure (see Box 1). We weighted outputs by cost to reflect differences in resource requirements – for example, knee surgery carries a greater weight than an outpatient appointment. Inputs were measured using staff volumes weighted by salaries, alongside spending on other inputs (adjusted for inflation, to account for changes in cost over time).

Data sources

We measured outputs using activity data from the Hospital Episode Statistics dataset and publicly available datasets for A&E and outpatient activity in NHS hospitals in England for all years between financial year 2018/19 and 2024/25. For inputs, we used the number of full-time equivalent staff and salaries from publicly available NHS workforce statistics. For bank and agency staff, we used expenditure data supplied directly by NHS England. For other associated inputs, we used expenditures from the Trust Accounts Consolidation datasets.

Approach

We measured trust efficiency for each year based on work by Castelli et al (2014), which calculates the ratio of outputs (cost-weighted activity) to inputs (staff, operating expenditures and the cost of using assets such as buildings or equipment) for each acute trust. Weighting activity by its cost ensures more resource-intensive services contribute more to overall output.

Outputs

Our outputs included activity in admitted patient care (elective and non-elective admissions), outpatient attendances (attended appointments only) and Type 1 (all specialty), Type 2 (single specialty) and Type 3 (urgent treatment centre or minor injury unit) A&E attendances.

These activities were cost-weighted to account for their differing resource-use intensity and as a proxy for their relative ‘value’. For example, a hip operation was given a higher value weighting than an outpatient appointment. For elective and non-elective admissions, we used cost weights from the National Cost Collection by Health Resource Group. We used constant 2024/25 prices to avoid conflating changes in activity costs with genuine changes in output. 

In line with other productivity measures, we adjusted the cost weights of activities that can be delivered in multiple care settings with equivalent clinical outcomes. For example, some procedures may be provided either as a day case or elective inpatient admission. Because differences in cost reflect the delivery setting rather than the value of the output produced, we assigned these activities a common cost weight equal to the average of the relevant settings. This adjustment was applied to activities delivered as either day case or elective inpatient admissions and to single-day and multi-day unplanned admissions.

Inputs

Inputs include:

  • Workforce: full-time equivalent staff, weighted by their salaries, plus expenditure on bank and agency staff
  • Operating expenditure: establishment and premises, drugs (not including high-cost drugs), health care purchases (likely to contain a workforce element), education, research and development, non-pay workforce costs, consultancy, legal, supplies and other operating expenditure
  • Costs of capital: includes depreciation and amortisation, which spread the cost of assets (like buildings, equipment or licences) held by a trust

Trust inclusion

We analysed acute, non-specialist NHS trusts with a Type 1, Type 2 or Type 3 A&E department and a complete series of output and input data from 2018/19 to 2024/25. Trusts exhibiting large, unexplained changes in measured efficiency outside the pandemic period were excluded (defined as a year-on-year change exceeding 40% outside of 2019/20–2020/21). While this process has tried to account for large, unexplained fluctuations in recorded activity, unaccounted for recording discrepencies may have impacted efficiency changes.

To account for mergers and organisational reconfigurations, we defined trusts according to their 2024/25 organisational structure and retrospectively mapped predecessor organisations onto them. This produced a consistent panel of 110 trusts observed throughout the study period.

Limitations

Our analysis has several limitations that should be considered when interpreting the results. 

Unlike the productivity measures produced by the ONS and the Centre for Health Economics, our measure does not include a quality adjustment. This was a deliberate choice to align the analysis more closely with the NHS England measure being used to assess progress toward the government’s 2% productivity target. As a result, the analysis captures changes in the volume of activity relative to inputs but not changes in the quality of care delivered. This approach has two key implications. First, trusts with more complex case mixes, particularly teaching and specialist trusts, may appear less efficient if the additional complexity of their activity is not fully captured by Health Resource Group cost weights. Second, any post-pandemic changes in quality, such as longer waiting times, worse outcomes or changes in readmission rates are not reflected in this measure. 

Our measure of outputs also has some drawbacks. Following established productivity methodologies, we equalised the value weights of activities that can be delivered in either day case or inpatient settings to avoid assigning lower value to equivalent activity delivered more efficiently. Unlike other measures of productivity (for example, from the ONS and NHS England), we were unable to apply similar adjustments where care may be delivered in outpatient settings. This was due to data limitations. Where organisations have made strong progress on shifting more care into outpatient settings, this may not be reflected as productivity gains in this work. The analysis focuses on admitted patient care, A&E and outpatient activity data and does not include some other forms of output, such as diagnostic activity. The efficiency of trusts that have expanded these activities may be understated. 

Although inputs were adjusted using the NHS capital and wage deflators, national deflators cannot fully capture variation in costs faced by individual trusts. We partially address this by multiplying staffing inputs by national average pay rates, reducing the influence of local pay differences. However, some trust-specific cost pressures, such as differences in energy and drug procurement costs, may not be fully reflected. As a result, some observed differences in measured efficiency may reflect unobserved variation in input costs rather than underlying efficiency.

Trust Accounts Consolidation data are primarily an accounting dataset and report how resources are recorded for financial reporting purposes rather than how inputs are used in delivering care. There is often a lag between investment and its impact on outputs, meaning increases in inputs may not translate into higher measured productivity in the short term. While accounting methods that spread investment costs over time can help improve alignment, they do not fully capture when or how those investments contribute to care delivery, which can lead to some distortion in productivity estimates.

The use of trust-level measures for this analysis may obscure more substantial variation at the service level. Variation at the Health Resource Group or point of delivery (elective, outpatient etc.) level may be wider, and these may be the levels at which improvement measures are being targeted. Further work is needed to assess variation at a more granular level. 

Table 1. Comparison of the Health Foundation’s efficiency measure with existing measures 

MeasureHealth FoundationNHS England (in-year)ONS annual (England)Centre for Health Economics (York)
CoverageAcute (non-specialist) trustsAll trusts, with the most reliable estimates for acute trusts (inc. specialist)Whole systemWhole system
LevelTrustTrustNationalNational
Frequency  AnnualMonthly (year-to-date)AnnualAnnual
Latest valueUp to financial year 2024/25H1 2025/26 vs H1 2024/25Up to 2022/23 (with experimental quarterly measures more recently)Up to financial year 2022/23
Quality adjustment? (eg for outcomes/experience)NoNo  Yes – produce quality-adjusted and non-quality-adjusted seriesYes – in quality-adjusted variants
EquivalisationRe-weighted to give equal weight to the same care delivered as overnight or day case care (but does not do the same for outpatient care)Re-weighted to give equal weight to the same care delivered as overnight stay or outpatient/day case careUndertaking a phased roll-out of re-weighting for the same procedures across modes of provision (including outpatient/day case/overnight and ambulance with/without conveyance)Re-weighted to give equal weight to the same care delivered as overnight or day case care

 

 

What has happened to efficiency nationally

We analysed efficiency across 110 acute NHS trusts between 2018/19 and 2024/25 and found a clear decline in their ability to convert resources (inputs) into activity (outputs). Historically, NHS inputs and outputs have followed a broadly linear relationship: trusts with greater resources generally deliver higher levels of activity. That relationship still holds but has weakened since the pandemic. In practical terms, the trusts in our sample now deliver less activity for a given level of input than they did before the pandemic. This reflects trends seen in other measures of efficiency, which also show NHS efficiency being below pre-pandemic levels.

The pandemic created a major operational shock, requiring trusts to reduce routine activity to manage surges in complex COVID-19 admissions and implement new ways of working to prevention and control infection. At the peak of disruption in 2020/21, trusts were around 28% less efficient than in 2018/19. Although cost-weighted activity is now higher than in 2018/19, as of 2024/25, efficiency remains around 14% below pre-pandemic levels. Our measured efficiency level remains below those reported by NHS England and the ONS, likely due to differing methodologies. For example, our approach does not equally weight outpatient activity and elective day case activity, nor include advice and guidance. There are also differences in the way we measured inputs (see Box 1).

Figure 1

The decline in efficiency since 2018/19 reflects input growth outpacing output (activity) growth (Figure 1). Across the trusts we analysed, cost-weighted activity in 2024/25 was around 12% higher than in 2018/19. Activity had increased across all major service areas included in our measure: A&E, outpatient care, and day case and inpatient care. Outpatient activity saw the largest rise, increasing by around 18%, compared with approximately 14% growth in A&E and 10% growth in inpatient and day case care. The strong growth in outpatient activity may partly reflect the continued shift of care into outpatient settings. However, inpatient and day case activity have also risen above pre-pandemic levels, suggesting this growth reflects an expansion of overall activity rather than simply a substitution of settings.

Despite this growth in outputs, inputs rose much faster. Between 2018/19 and 2024/25, inputs increased by 30%. Workforce costs increased by 25%, while operating expenditure and cost of capital rose by 36%. Efficiency measured as outputs per worker recovered more strongly than efficiency measured as outputs relative to operating expenditure. This suggests that rising operating expenditure accounts for a larger share of the decline in overall efficiency.

 

How efficiency has varied

Looking beneath the national trend, there is meaningful variation in efficiency across trusts. In 2024/25, the trust at the 90th percentile of efficiency produced around 56% more outputs per unit of measured input than the 10th percentile trust (Figure 2), equivalent to being 1.6 times as efficient. This gap narrowed slightly after the pandemic but remains modest compared with the wider economy. Using a comparable measure for large companies (over 250 employees), the 90th percentile firm is around 3 times as efficient as the 10th percentile. This suggests there is less variation in efficiency between trusts than between organisations in the wider economy.

To assess post-pandemic recovery among the most efficient trusts (the ‘frontier’), we used the 90th percentile as a proxy. Efficiency among this frontier fell by 28% during the pandemic, and despite some recovery, remains around 15% below its pre-pandemic level. This suggests that even the highest performing trusts have yet to recover. 

By this measure, relative positions across trusts have been broadly stable. Comparing the 90th percentile with the median shows that the typical trust has remained at a similar distance from the frontier since 2018/19. By 2024/25, the frontier remained 20% more efficient than the median, broadly unchanged from its pre-pandemic level. This suggests it is not a shifting of the frontier and a ‘catch-up’, but a systemic shift downwards across the board. 

Overall, this evidence suggests that while the variation between trusts has stayed broadly similar, efficiency has fallen across the board. If poorer-performing trusts were driving this trend, we would expect the gap to have widened as these fell further behind. Equally, if stronger trusts were driving recovery, the gap would also have widened as they pulled ahead. As neither pattern is observed, it seems there is a common constraint affecting all trusts, including the highest performers. This points away from a simple ‘leaders and laggards’ explanation and instead suggests a system-wide decline in efficiency. 

Figure 2

 

What’s behind this variation

With variation and relative trust positions remaining broadly stable over time, we examined how efficiency changed for trusts at the top and bottom of the distribution post-pandemic. This helps identify whether differences in trust characteristics, inputs or outputs may explain variation in recovery.

We grouped trusts from the top and bottom quartiles of efficiency in 2018/19 and tracked them over time. While all trusts experienced a sharp deterioration in efficiency during the pandemic, recovery has been uneven. Between 2018/19 and 2024/25, trusts in the lowest quartile recovered more quickly on average than those in the highest (Figure 3), slightly narrowing the gap between the two groups.

Figure 3

Figure 4 shows that, for trusts at both ends of the distribution, inputs rose far faster than outputs (by around 28–32% versus roughly 10–12%). In both cases, the increase was dominated by operating expenditure rather than workforce costs. In other words, the same pattern of inputs rising faster than outputs and being concentrated on the non-staff side appears among the most efficient trusts as well as the least. If the current efficiency shortfall were a matter of inefficiency being concentrated in least efficient trusts, these input pressures would have been localised in the bottom quartile; that the shortfall appears across the distribution indicates the rising cost of inputs constraining efficiency improvement across all trusts.

Figure 4

Some of these differences may reflect the composition of trusts within each group. Of the 27 trusts in the bottom quartile in 2018/19, 22 remained there in 2024/25. These trusts had higher spending on research and development and accounted for around 40% of teaching trusts nationally. Activities such as research and training may not be fully captured in standard measures of productivity, potentially understating the measured efficiency of these trusts.

In comparison, only 16 of the 27 trusts in the top quartile remained there in 2024/25, suggesting that top-ranking trusts are less stable over time. This group was less research intensive, included a smaller share of teaching trusts and accounted for a slightly smaller share of total cost-weighted activity relative to its share of trusts.

Taken together, these findings suggest that differences in post-pandemic recovery reflect both variation in activity growth and differences in input growth. They also indicate that some of the apparent narrowing of differences between trusts may reflect a natural ‘bounceback’, with initially lower-performing trusts having more room for recovery after the pandemic shock.

 

Discussion and implications

Improving efficiency is a central policy objective, with recent NHS England plans setting out a target of 2% sustained annual efficiency growth and a programme of measures focused on variation reduction, operational improvement and better use of existing capacity.

To understand how NHS efficiency has evolved since the pandemic, we examined the extent of variation across trusts and the relative impact of changes in average performance versus the dispersion of efficiency levels across trusts.

Our findings suggest that the post-pandemic efficiency shortfall is best understood as a system-wide decline rather than a widening gap between higher and lower-performing trusts. This has important implications for current and future policy approaches.

First, the fall in efficiency across the entire distribution, including at the frontier, indicates that constraints are system wide rather than concentrated in underperforming trusts. This aligns with NHS England’s emphasis on pressures such as bed occupancy, delayed discharge, diagnostics and workforce capacity. It also suggests that policies focused primarily on identifying and correcting ‘low performers’ or reducing variation are unlikely to be sufficient on their own. Such policies may provide a one-off boost to system-level efficiency, but they will not address the shared structural constraints affecting all providers.

Second, the distance between median and frontier performance has changed little since before the pandemic. This stability implies that closing gaps between trusts can contribute to improvement but is unlikely to drive system-wide recovery over the long term. These findings also highlight the limitations of technical efficiency as a measure. Not all cross-trust differences should be interpreted as inefficiencies, particularly given variations in their case mixes and organisational functions, such as teaching and research activity. Current efficiency measures do not go far enough to distinguish between unavoidable costs and low efficiency amenable to intervention. Refining efficiency measures to appropriately capture such activities would be an improvement in this area.

Third, weak efficiency growth appears more attributable to rising non-workforce costs than to labour-related factors. While efficiency as measured by outputs per worker has shown some recovery, spending on servicing capital and operating expenditure – including on estates, supplies, drugs and outsourced services – has risen more rapidly. Some of this improvement in outputs per worker may have been driven by post-COVID-19 efforts to reduce spending on temporary staff. The reasons for increases in other inputs are less clear, but increases in drugs costs and overheads such as energy costs are contributing factors. We did not find evidence of input costs being driven by investments in new buildings and equipment (referred to as ‘capital deepening’), but rather by an increase in the running costs associated with capital.

Overall, reducing variation between trusts can support a one-off boost to system-wide efficiency, but on its own is unlikely to close the post-pandemic efficiency gap or to lead to a sustained higher level of efficiency. Because the shortfall is largely common across providers, restoring efficiency growth also will require system-wide interventions that address shared constraints on capacity and input costs.

Further reading

Related content